Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

ProMetic Raises C$26.2M For Peptide Mimetics, rAAT Drug

June 18, 2002

ProMetic Raises C$26.2M For Peptide Mimetics, rAAT Drug

June 18, 2002

Abbott Reports Positive Data From Anti-TNF RA Antibody

June 17, 2002

Abbott Reports Positive Data From Anti-TNF RA Antibody

June 17, 2002

Enanta Financing Nets $18M To Advance 'Drug Morphing'

June 14, 2002

Enanta Financing Nets $18M To Advance 'Drug Morphing'

June 14, 2002

Millennium's Velcade Entering Phase III For Multiple Myeloma

June 13, 2002

Millennium's Velcade Entering Phase III For Multiple Myeloma

June 13, 2002

Favrille Series B Gets $16.9M To Pay For Ongoing Studies

June 12, 2002

Gilead, Anadys Enter Deal For HTP With Viral Target

June 11, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...